Susanne Keiding Selected Research

2-deoxy-2-fluorogalactose

1/2020	[18 F]-Fluoro-2-deoxy-D-galactose positron emission tomography/computed tomography as complementary imaging tool in patients with hepatocellular carcinoma.
4/2014	The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
6/2013	Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
9/2011	The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
5/2011	Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Keiding Research Topics

Disease

15	Hepatic Encephalopathy 03/2014 - 01/2006
13	Fibrosis (Cirrhosis) 01/2014 - 01/2006
10	Neoplasms (Cancer) 06/2020 - 07/2002
7	Hyperammonemia 08/2013 - 06/2007
6	Liver Cirrhosis (Hepatic Cirrhosis) 04/2014 - 03/2009
5	Hypoxia (Hypoxemia) 10/2010 - 01/2002
4	Liver Diseases (Liver Disease) 04/2014 - 06/2009
4	Carcinoma (Carcinomatosis) 07/2005 - 01/2002
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2011
3	Portal Hypertension 11/2018 - 11/2011
2	Cholestasis 01/2017 - 01/2016
2	Brain Edema (Cerebral Edema) 03/2014 - 08/2013
2	Hodgkin Disease (Hodgkin's Disease) 04/2006 - 01/2006
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2006 - 12/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2005 - 07/2002
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Pneumoperitoneum 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 12/2015
1	Inflammation (Inflammations) 02/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2014
1	Edema (Dropsy) 09/2011
1	Brain Neoplasms (Brain Tumor) 07/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2011
1	End Stage Liver Disease 02/2011
1	Lung Neoplasms (Lung Cancer) 02/2009
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2009
1	Fibrosarcoma 03/2008
1	Cholangiocarcinoma 12/2006
1	Sclerosing Cholangitis 12/2006
1	Necrosis 07/2005
1	Sarcoma (Soft Tissue Sarcoma) 06/2003

Drug/Important Bio-Agent (IBA)

14	AmmoniaIBA 03/2014 - 01/2006
8	Galactose (Galactopyranose)FDA LinkGeneric 01/2020 - 06/2009
5	2-deoxy-2-fluorogalactoseIBA 01/2020 - 05/2011
5	Glutamine (L-Glutamine)FDA Link 03/2014 - 01/2006
5	Oxygen (Dioxygen)IBA 01/2013 - 06/2003
5	fluoromisonidazoleIBA 10/2010 - 01/2002
3	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 07/2002
3	Branched-Chain Amino AcidsIBA 06/2013 - 03/2009
3	Tricarboxylic AcidsIBA 04/2011 - 06/2007
2	CopperIBA 01/2022 - 06/2020
2	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 03/2014 - 08/2013
2	Alanine (L-Alanine)FDA Link 08/2013 - 09/2011
2	Pharmaceutical PreparationsIBA 08/2013 - 02/2009
2	Amino Acids FDA Link 08/2011 - 03/2009
2	ErbB Receptors (EGF Receptor)IBA 07/2011 - 02/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2011 - 02/2009
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2006 - 07/2005
1	obeticholic acidIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	cholylsarcosineIBA 01/2017
1	Insulin (Novolin)FDA Link 12/2015
1	Scavenger Receptors (Scavenger Receptor)IBA 02/2015
1	Hemoglobins (Hemoglobin)IBA 02/2015
1	Acetates (Acetic Acid Esters)FDA Link 01/2014
1	Propranolol (Inderal)FDA LinkGeneric 08/2013
1	Methionine SulfoximineIBA 08/2013
1	OrnithineIBA 01/2013
1	ornithine phenylacetateIBA 01/2013
1	phenylacetic acid (phenylacetate)FDA Link 01/2013
1	Gefitinib (Iressa)FDA Link 07/2011
1	gamma-Aminobutyric Acid (GABA)IBA 06/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2011
1	Biological ProductsIBA 06/2009
1	Glutamic Acid (Glutamate)FDA Link 03/2009
1	CarbonIBA 03/2009
1	Isoleucine (L-Isoleucine)FDA Link 03/2009
1	thiazolyl blueIBA 02/2009
1	Ethanol (Ethyl Alcohol)IBA 01/2009
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2009
1	microsomal ethanol-oxidizing system (MEOS)IBA 01/2009
1	Coloring Agents (Dyes)IBA 03/2008
1	pimonidazoleIBA 03/2008
1	fluoroazomycin arabinosideIBA 03/2008
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 03/2008
1	Ketoglutarate Dehydrogenase Complex (Oxoglutarate Dehydrogenase)IBA 06/2007
1	Pyruvic Acid (Pyruvate)IBA 06/2007
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2006
1	fluoroerythronitroimidazoleIBA 04/2004
1	Fluorine-18IBA 04/2004
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2002

Therapy/Procedure

5	Electrodes (Electrode) 10/2010 - 01/2002
2	Radiotherapy 03/2006 - 12/2004
1	Punctures 11/2018
1	Laparotomy 01/2017
1	Catheters 01/2016
1	Denervation 12/2015
1	Ligation 06/2013
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2011
1	Stents 11/2011
1	Transjugular Intrahepatic Portasystemic Shunt 11/2011
1	Liver Transplantation 12/2006
1	Therapeutics 04/2006
1	Drug Therapy (Chemotherapy) 01/2006